Biotech Solutions — Delve Health

Lean operations

Fewer vendors

One platform + one team

Study execution

Faster

Configured and deployed in days

Data quality

Cleaner

Real-time QC + human follow-through

Built for emerging biotech teams

Move Fast. Stay Aligned.
Deliver Real Evidence.

Delve Health helps biotechs run efficient, high-quality decentralized and hybrid studies without massive internal teams or complex multi-vendor setups. Unified data capture, real-time oversight, and human support keep execution on track from first patient to readout.

Book a Biotech Demo Talk to a Study Expert

Less overhead · Faster timelines · More defensible evidence.

eCOA
DEV
QC
HUMAN

Unified Study Execution

Build → Deploy → Monitor → Resolve

Patient missed a diary and the wearable stopped syncing.
Concierge intervenes immediately—restores sync, confirms completion, logs the outcome.
QC flags risk early so the team stays aligned and the endpoint remains usable.
One partner Platform + people to execute end-to-end

Your Study Needs Speed — Not Complexity

Biotechs need to move quickly, operate lean, and build evidence that stands up to regulatory scrutiny. Delve Health brings together eCOA, wearables, diaries, patient engagement, and concierge support into one platform purpose-built for smaller teams.

  • Fit-for-purpose eCOA + wearable platform
  • Reduced operational burden for small teams
  • Adaptive workflows for early-phase trials
  • Faster deployment with minimal IT overhead
Biotech Research Platform

Built for Emerging Biotechs

Move fast without sacrificing data quality. Delve gives lean teams a unified platform for eCOA, wearables, and compliance—backed by real humans when execution gets messy.

Fast Deployment

Launch eCOA and wearables in weeks, not months.

Fit-for-Purpose Endpoints

Validated digital biomarkers aligned with regulatory expectations.

Human Concierge

Multilingual outreach keeps participants engaged and compliant.

Lean Team Ready

Automated oversight plus human support reduces operational load.

eCOA + Wearables in One Place

Early-phase and exploratory studies rely on accurate, continuous data. Delve provides a single, validated infrastructure for collecting both subjective and objective endpoints.

  • Wearable endpoints aligned with FDA/EMA frameworks
  • ePRO + symptom scoring with audit trails
  • Real-time device and diary compliance monitoring
  • Objective–subjective signal correlation
Biotech eCOA Wearables

Stronger Early Data With Human Support

Early-phase studies struggle with variability. When a patient gets stuck, a device misbehaves, or a diary is missed — our concierge intervenes in real time to protect data quality.

  • Daily oversight of patient signals
  • Proactive sync + battery troubleshooting
  • Visit reminders and adherence coaching
  • Significant reduction in missingness
Biotech Engagement Support

Powering Evidence for Emerging Biotechs

Early-Phase Digital Endpoint Study

Objective signals validated against gold-standard methods.

Decentralized Rare Disease Trial

92% ePRO completion across a hard-to-reach population.

Exploratory Biomarker Program

35% faster data readouts with real-time dashboarding.

92%

ePRO Completion

87%

Patient Retention

95%

Wearable Compliance

30%

Faster Interim Readouts

Move Your Science Forward — Faster.

One platform. Validated endpoints. Human retention. Everything a biotech needs to scale evidence.

Book a Biotech Demo